Cell Signaling – News and Features

The new company will provide an integrated pipeline of products in the functional biology and drug discovery space.

The study opens an avenue to develop therapeutic drugs to target the epidermal growth factor receptor genes.

The goals of the collaboration are to further investigate intracellular signaling mechanisms underlying stem cell self-renewal.

Studies will be performed with CST's PhosphoScan™ technology to identify phosphorylation profiles of kinase targeted lead compounds.

Fujitsu will provide Whitehead with the CELLINJECTOR automated microinjection system.

Researchers have discovered a single point mutation in the JAK2 gene.

The study counters a longstanding belief that cancer cells become "addicted" to the cancer-causing gene RAS.

GeneGo has extended its software with a metabolomics parser.

The approach scans the tumor for evidence of widespread genetic changes.

DiscoveRx will provide initial access to their PathHunter technology for small molecule screening.